| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/29/2001 | CA2328775A1 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives |
| 06/29/2001 | CA2293913A1 Treatment of necrotizing infections |
| 06/28/2001 | WO2001046696A2 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046408A2 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046390A2 Method of inactivating microorganisms |
| 06/28/2001 | WO2001046383A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046223A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | WO2001046212A1 Treatment of viral infections using levovirin?tm¿ |
| 06/28/2001 | WO2001046211A1 Method for preparing and isolating 9-deoxo-9(z)-hydroxyiminoerythromycin a |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046185A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046172A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | WO2001046164A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 06/28/2001 | WO2001046158A1 Method for production of a triazolinethione derivative |
| 06/28/2001 | WO2001046157A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | WO2001046150A2 Quinolone compounds for use in treating viral infections |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001045753A1 Apparatus and method of treatment of wounds, burns and immune system disorders |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045748A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045738A2 Use of heat shock proteins to enhance production of chemokines by a cell |
| 06/28/2001 | WO2001045732A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/28/2001 | WO2001045727A2 Stabilized veterinary compositions comprising more than one antiviral agent |
| 06/28/2001 | WO2001045726A2 The use of procyanidins in the modulation of cytokine gene expression and protein secretion |
| 06/28/2001 | WO2001045725A2 Treatment for inflammatory bowel disease (ibd) and related conditions |
| 06/28/2001 | WO2001045723A1 Medicines manufactured from old platycodon extracts |
| 06/28/2001 | WO2001045721A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin |
| 06/28/2001 | WO2001045718A1 A method of treating infectious diseases |
| 06/28/2001 | WO2001045712A1 Combinations of medicaments for treating viral diseases |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045691A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | WO2001045679A2 Use of chemotherapeutic agents for topical treatment |
| 06/28/2001 | WO2001045667A2 Water-soluble powders for oral solution and use thereof |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045585A1 Dental prosthesis with means for the release of active substances |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001040442A8 Novel bacterial isolate and the preparation and use of its active metabolites |
| 06/28/2001 | WO2001037667A8 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2001005974A9 The il-1l1 gene and polypeptide products |
| 06/28/2001 | WO2001005414A8 Algae protein polysaccharide extraction and use thereof |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 06/28/2001 | WO2000076527A3 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000075142A3 Dna methyltransferase inhibitors |
| 06/28/2001 | WO2000074693A3 Immunity generation |
| 06/28/2001 | WO2000071725A3 Combination neisserial compositions |
| 06/28/2001 | WO2000071149A3 Therapeutic uses of bpi protein products in humans with otitis media with effusion |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000067697A3 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000042987A8 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | US20010005716 Core of an acid labile medicant such as didanosine, a binder and a disintegrant, and a coating of a methacrylic acid copolymer and plasticizer which protects drug at low pH but releases drug at pH of 4.5 or higher, anti-adherent |
| 06/28/2001 | US20010005712 Parenterally administering Product R, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating AIDS or HIV infections including HIV protease inhibitors and nucleosides |
| 06/28/2001 | US20010005510 Anti-fungal composition |
| 06/28/2001 | DE19962933A1 New ascosalipyrrolone derivatives, useful as antibacterials for human or veterinary medicine, produced by new Ascochyta fungus |
| 06/28/2001 | DE19961603A1 Production of 2-chlorocyclopropyl-1-chlorophenyl-triazolonyl-propanol derivative, useful as microbicide, from 2-chlorocyclopropyl-2-chlorobenzyl-oxirane |
| 06/28/2001 | DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2717246A1 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395429A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 06/28/2001 | CA2395300A1 Novel compounds |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2395125A1 A method of treating infectious diseases |
| 06/28/2001 | CA2395113A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | CA2395108A1 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394997A1 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/28/2001 | CA2394877A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394635A1 Apparatus and method of treatment of wounds, burns and immune system disorders |
| 06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |